CPRX - Catalyst Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference 2024 | Benzinga
CORAL GABLES, Fla., May 28, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (NASDAQ:CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases today announced that Richard J. Daly, President and CEO of Catalyst, along with other members of Catalyst's management team, will participate at the upcoming Jefferies Global Healthcare Conference 2024 on Wednesday, June 5, 2024, in New York.
| Presentation Details: |
| Date: |
| Wednesday, June 5, 2024 |
| Time: |
| 3:30 PM ET |
| Location: |
| New York, NY |
The webcast will be available under the Investors section on the Company's website, www.catalystpharma.com, and a replay will be available for at least 14 days.
About Catalyst Pharmaceuticals, Inc.
With exceptional patient focus, Catalyst is committed to developing and commercializing innovative first-in-class medicines that address rare and difficult-to-treat diseases. Catalyst's flagship U.S. commercial product is FIRDAPSE® ...